Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,243 | -1,919 | -6,849 | -5,419 | -3,821 |
| Depreciation Amortization | 100 | 50 | 171 | 122 | 90 |
| Accounts payable and accrued liabilities | 460 | 6 | 69 | 16 | -36 |
| Other Working Capital | 1,052 | 278 | 581 | 661 | 492 |
| Other Operating Activity | -457 | -3 | -26 | 21 | 37 |
| Operating Cash Flow | $-3,089 | $-1,589 | $-6,054 | $-4,599 | $-3,239 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -158 | -15 | -174 | N/A | N/A |
| Investing Cash Flow | $-158 | $-15 | $-174 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -1 | -4 | -3 | -2 |
| Common Stock Issued | 8,625 | 125 | 7,094 | 3,847 | 3,847 |
| Other Financing Activity | -942 | 0 | 0 | -465 | -465 |
| Financing Cash Flow | $7,681 | $124 | $7,090 | $3,379 | $3,380 |
| Beginning Cash Position | 5,165 | 5,165 | 4,302 | 4,302 | 4,302 |
| End Cash Position | 9,599 | 3,685 | 5,165 | 3,082 | 4,443 |
| Net Cash Flow | $4,434 | $-1,480 | $863 | $-1,220 | $141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,089 | -1,589 | -6,054 | -4,599 | -3,239 |
| Capital Expenditure | -162 | -19 | -174 | N/A | N/A |
| Free Cash Flow | -3,250 | -1,608 | -6,227 | -4,599 | -3,239 |